A synthetic peptide for use as a blocking control in assays to test for specificity of ADRA1 B antibody, Alternative Names: ADRA1B control peptide, ADRA1B antibody Blocking Peptide, Anti-ADRA1B Blocking Peptide, adrenergic, alpha-1B-, receptor Blocking Peptide, ADRA1 Blocking Peptide, ALPHA1BAR Blocking Peptide, ADRA1B, ADRAB-1, ADRAB 1, ADRAB-1 Blocking Peptide, ADRAB 1 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
ADRA1B
(Adrenergic, alpha-1B-, Receptor (ADRA1B))
Hintergrund
Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1B-adrenergic receptor, which induces neoplastic transformation when transfected into NIH 3T3 fibroblasts and other cell lines. Thus, this normal cellular gene is identified as a protooncogene. This gene comprises 2 exons and a single large intron of at least 20 kb that interrupts the coding region.